Hizal M, Bilgin B, Paksoy N, Acikgoz O, et al. The real-life efficacy and safety of osimertinib in pretreated advanced non-small cell lung cancer patients with T790M mutation: a Turkish Oncology Group Study. J Cancer Res Clin Oncol 2021 Jul 31. pii: 10.1007/s00432-021-03748.
PMID: 34331582